Teladoc Health (TDOC) Scheduled to Post Earnings on Wednesday

Teladoc Health (NYSE:TDOC - Get Free Report) will issue its quarterly earnings data after the market closes on Wednesday, October 30th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Individual interested in participating in the company's earnings conference call can do so using this link.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.36) by $0.08. The company had revenue of $642.44 million for the quarter, compared to analysts' expectations of $649.34 million. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. On average, analysts expect Teladoc Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Teladoc Health Stock Performance

TDOC traded down $0.35 during trading on Wednesday, hitting $8.66. The stock had a trading volume of 5,059,551 shares, compared to its average volume of 5,449,254. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66. The firm has a market capitalization of $1.47 billion, a P/E ratio of -6.16 and a beta of 0.91. The company's 50-day moving average price is $8.21 and its 200 day moving average price is $9.93. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $22.54.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Oppenheimer dropped their price objective on shares of Teladoc Health from $21.00 to $17.00 and set an "outperform" rating on the stock in a research note on Thursday, August 1st. JPMorgan Chase & Co. lowered their price target on shares of Teladoc Health from $16.00 to $9.00 and set a "neutral" rating on the stock in a research note on Monday, August 26th. Evercore ISI upped their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. Canaccord Genuity Group lowered their price target on shares of Teladoc Health from $25.00 to $17.00 and set a "buy" rating on the stock in a research note on Thursday, August 1st. Finally, Truist Financial lowered their price target on shares of Teladoc Health from $15.00 to $10.00 and set a "hold" rating on the stock in a research note on Friday, August 2nd. Fifteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Teladoc Health currently has an average rating of "Hold" and an average price target of $11.81.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the company's stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, insider Vidya Raman-Tangella sold 3,857 shares of the stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares in the company, valued at $274,049.38. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Thomas Mckinley acquired 4,000 shares of the business's stock in a transaction dated Thursday, September 12th. The shares were bought at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the acquisition, the director now owns 39,077 shares in the company, valued at approximately $300,502.13. This trade represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders have sold 57,377 shares of company stock worth $438,054. Corporate insiders own 0.95% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.